Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Vanda Pharmaceuticals
Age
12–17
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
males or females 12-17 years of age.
in a stable housing situation with a guardian/parent who can encourage compliance with the study protocol.
with diagnosis of disorder requiring treatment with an antipsychotic agent.
having a Children's Global Assessment of Severity Scale (CGAS) of 41 or greater.
Heart rate \</=100 beats per minute and \>/= 50 beats per minute.
You may not be if
Patients with mild, moderate or severe mental retardation (i.e., documented IQ \<70), do not have the capacity to assent, cannot understand the informed consent, or participate fully in the assessments.
Hospitalized due to suicidal ideation or suicidal behavior, history of suicidal ideation within 6 months prior to screening, history of suicidal behavior within 2 years prior to screening.
Pregnant, females who can become pregnant and lactating females.
Known hypersensitivity to iloperidone and to related drugs.
Clinical conditions (Neurological, metabolic, hepatic, renal, hematological, pulmonary, cardiovascular, gastrointestinal or urological), which may pose significant risk to patients or impair reliable study participation.
